China’s NMPA has approved InnoCare Pharma’s orelabrutinib for use as a first-lin...
Granite Bio has secured $100m in funding for its new antibody treatments that ta...
The EC has granted orphan drug designation to Dyne Therapeutics’ DYNE-251 for tr...
The top 20 biopharmas demonstrated a strong start to 2025, despite ongoing uncer...
MSD is also bracing for a $200m hit due to tariffs as it accelerates US manufact...
CDMOs are crucial partners in alum-based vaccine production, managing aseptic fi...
Following in the footsteps of several pharma companies, life sciences giant Ther...
Merck KGaA has confirmed that it is in late-stage discussions with SpringWorks, ...
Despite the decision being a win for Novo Nordisk, the compounded drugs sector i...
The FDA has granted approval to Akeso's differentiated programmed cell death pro...
Caribou is scaling back its operations, halting multiple programmes, and cutting...
Veraxa Biotech will gain access to $253m in cash from Voyager to advance its can...
Contraception for women has seen little change over the past 50 years, with the ...
EditCo Bio has entered a licensing agreement to secure access to Promega’s prote...
The expiration of the FDA’s paediatric priority review voucher programme is crea...
The agreement gives Boehringer access to Tessellate’s novel approach targeting A...
